The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells

Abstract

Abacavir is one of the most efficacious nucleoside analogues, with a well-characterized inhibitory activity on reverse transcriptase enzymes of retroviral origin, and has been clinically approved for the treatment of AIDS. Recently, Abacavir has been shown to inhibit also the human telomerase activity. Telomerase activity seems to be required in essentially all tumours for the immortalization of a subset of cells, including cancer stem cells. In fact, many cancer cells are dependent on telomerase for their continued replication and therefore telomerase is an attractive target for cancer therapy. Telomerase expression is upregulated in primary primitive neuroectodermal tumours and in the majority of medulloblastomas suggesting that its activation is associated with the development of these diseases. Therefore, we decided to test Abacavir activity on human medulloblastoma cell lines with high telomerase activity. We report that exposure to Abacavir induces a dose-dependent decrease in the proliferation rate of medulloblastoma cells. This is associated with a cell accumulation in the G 2 /M phase of the cell cycle in the Daoy cell line, and with increased cell death in the D283-MED cell line, and is likely to be dependent on the inhibition of telomerase activity. Interestingly, both cell lines showed features of senescence after Abacavir treatment. Moreover, after Abacavir exposure we detected, by immunofluorescence staining, increased protein expression of the glial marker glial fibrillary acidic protein and the neuronal marker synaptophysin in both medulloblastoma cell lines. In conclusion, our results suggest that Abacavir reduces proliferation and induces differentiation of human medulloblastoma cells through the downregulation of telomerase activity. Thus, using Abacavir, alone or in combination with current therapies, might be an effective therapeutic strategy for the treatment of medulloblastoma. ' 2009 UICC

Regulatory roles of LINE-1-encoded reverse transcriptase in cancer onset and progression

“…1C), including the appearance of dendritic-like extensions and increased adhesion to the plate surface, distinctive of differentiating melanoma (see [78] for an in-depth characterization), are accompanied by global alterations of the transcriptome of coding and non-coding sequences, as will be seen below. Several laboratories have independently confirmed these conclusions in studies of various human tumorigenic cell lines treated with RT inhibitors, both of the nonnucleoside [80, 81, 82] and the nucleoside type [83, 84, 85]. …”

Beneficial and Detrimental Effects of Antiretroviral Therapy on HIV-Associated Immunosenescence

“…This hypothesis stems from the evidence that NRTIs inhibit HIV-1 reverse transcriptase as well as eukaryotic pol-γ (the mtDNA replicase that also possesses reverse transcriptase activity) [155]. In the early times of HIV epidemic, NRTIs, including azidothymidine (AZT), didanosine (ddI), and abacavir (ABC) [156-160] were proven to be able to reduce telomerase activity and TL in vitro. More recently, tenofovir (TDF), lamivudine (3TC), and emtricitabine (FTC) have also been found to diminish telomerase activity and TL in vitro [161].…”

HIV-associated cellular senescence: A contributor to accelerated aging

“…Senescence was induced in medulloblastoma cell lines treated with the NRTI abacavir (Rossi et al, 2009). However, being an immortalized cell line the senescence induction appeared to be related to the inhibition of telomerase.…”